EDGAR Filing Documents for 0001415889-13-000713

Form 8-K - Current report:

SEC Accession No. 0001415889-13-000713

Filing Date

2013-04-10

Accepted

2013-04-10 17:30:03

Documents

Period of Report

2013-04-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		vsta8kapr102013.htm	8-K	32593
2		ex10-1.htm	EX-10.1	250781
3		ex10-2.htm	EX-10.2	48250
4		ex10-3.htm	EX-10.3	97773
5		ex99-1.htm	EX-99.1	16326
6		vstalogo.jpg	GRAPHIC	4649
	Complete submission text file	0001415889-13-000713.txt		453496

Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080

Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224

VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)